Advances in science, data and technology are revolutionizing healthcare and unlocking potential in good health and wellness

longevity FUND LP


A early-stage venture capital fund investing in the frontiers of human optimization to enhance how we live, learn, work, play, and experience the world.
Purpose:
Ensure healthy lives and promote well-being for all at all ages
Stage:
Pre-seed, seed, series+
Focus
​areas:
Brain-Computer Interfaces
Digital Therapeutics
Healthcare Blockchain
Longevity & Anti-Aging
​New Pharmacology
Quantum Computing
Investment
​size:
Up to $5m USD
Geography:
Global; North American focus

Value-add

Limited Partners
  • Portfolio exposure to frontier human optimization
  • Non-dilutive CAD government funds
  • Robust investment pipeline of frontier human optimization companies
  • Investment committee with deep experience in frontier healthcare and technology
  • Strong advisory team and network of later stage funds to help with due diligence
  • Diversified portfolio with low correlation to broad market indices
Target Companies
  • Early stage investors enabling scientific research and experimental development
  • Flexible investors with no revenue or EBITDA min
  • Long time horizon up to 10 years
  • Government grant funding available
  • Corporate development and board advisory 
  • Large network of growth and later stage funds for introductions​
  • Commitment to participate in subsequent rounds of financing
No Offer or Solicitation of Securities: This document is meant for the direct recipient of the Investment Manager for general discussion purposes only and does not constitute an offer to sell or buy any security in any jurisdiction. Reproduction or further distribution of any part of this document is strictly prohibited.